These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32956894)

  • 1. Unfavorable Outcome After Good Grade Aneurysmal Subarachnoid Hemorrhage: Exploratory Analysis.
    Eagles ME; Tso MK; Ayling OGS; Wong JH; MacDonald RL
    World Neurosurg; 2020 Dec; 144():e842-e848. PubMed ID: 32956894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early predictors of prolonged stay in a critical care unit following aneurysmal subarachnoid hemorrhage.
    Witiw CD; Ibrahim GM; Fallah A; Macdonald RL
    Neurocrit Care; 2013 Jun; 18(3):291-7. PubMed ID: 23371849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
    Eagles ME; Tso MK; Macdonald RL
    J Neurosurg; 2019 Aug; 131(2):420-425. PubMed ID: 30117765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.
    Giede-Jeppe A; Reichl J; Sprügel MI; Lücking H; Hoelter P; Eyüpoglu IY; Kuramatsu JB; Huttner HB; Gerner ST
    J Neurosurg; 2020 Feb; 132(2):400-407. PubMed ID: 30717052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
    Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage.
    Zhao B; Yang H; Zheng K; Li Z; Xiong Y; Tan X; Zhong M;
    J Neurosurg; 2017 Jun; 126(6):1764-1771. PubMed ID: 27367238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Shunt-Dependent Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage.
    Tso MK; Ibrahim GM; Macdonald RL
    World Neurosurg; 2016 Feb; 86():226-32. PubMed ID: 26428322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of global cerebral atrophy on clinical outcome after subarachnoid hemorrhage.
    Tam AK; Kapadia A; Ilodigwe D; Li Z; Schweizer TA; Macdonald RL
    J Neurosurg; 2013 Jul; 119(1):198-206. PubMed ID: 23662822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
    Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
    Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia After Aneurysmal Subarachnoid Hemorrhage Is Associated With Poor Outcome and Death.
    Ayling OGS; Ibrahim GM; Alotaibi NM; Gooderham PA; Macdonald RL
    Stroke; 2018 Aug; 49(8):1859-1865. PubMed ID: 29946013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.
    Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G
    J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient phenotypes associated with outcomes after aneurysmal subarachnoid hemorrhage: a principal component analysis.
    Ibrahim GM; Morgan BR; Macdonald RL
    Stroke; 2014 Mar; 45(3):670-6. PubMed ID: 24425125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
    Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
    Acta Neurochir Suppl; 2013; 115():27-31. PubMed ID: 22890639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of Vasospasm with Clazosentan After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
    Higashida RT; Bruder N; Gupta R; Guzman R; Hmissi A; Marr A; Mayer SA; Roux S; Weidauer S; Aldrich EF
    World Neurosurg; 2019 Aug; 128():e639-e648. PubMed ID: 31054336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfavorable Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage WFNS Grade I.
    Zijlmans JL; Coert BA; van den Berg R; Sprengers MES; Majoie CBLM; Vandertop WP; Verbaan D
    World Neurosurg; 2018 Oct; 118():e217-e222. PubMed ID: 29966780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
    Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
    Lancet Neurol; 2011 Jul; 10(7):618-25. PubMed ID: 21640651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of body mass index on outcome after aneurysmal subarachnoid hemorrhage treated with clipping versus coiling.
    Rinaldo L; Hughes JD; Rabinstein AA; Lanzino G
    J Neurosurg; 2018 Sep; 129(3):658-669. PubMed ID: 29027862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
    World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Elderly Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage.
    Yoshikawa S; Kamide T; Kikkawa Y; Suzuki K; Ikeda T; Kohyama S; Kurita H
    World Neurosurg; 2020 Dec; 144():e743-e749. PubMed ID: 32949799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.